Clinical Trials Logo

Clinical Trial Summary

This research is being done to determine how well cardiac computed tomography (CT) scanning measures of fat within the heart can predict abnormal heart rhythms and how well cardiac CT can measure scar within the heart versus cardiac magnetic resonance imaging (MRI). - People who have been enrolled in PROSe-ICD (NA_00045142) and Reynolds (NA_00037404) studies may join - The procedures, tests, drugs or devices that are part of this research and will be paid for by the study


Clinical Trial Description

The investigators aim to investigate the role of intramyocardial fat on ventricular arrhythmogenesis. Intramyocardial fat deposition has been frequently observed in patients with ischemic heart disease and is readily detectable by multi-detector computed tomography (MDCT) with high sensitivity and specificity, unlike other modalities. Like intramyocardial fat, reentrant ventricular tachycardia (VT) tends to occur late after the onset of myocardial infarction and the investigators hypothesize that lipomatous metaplasia within the infarct may precipitate later onset ventricular arrhythmias (VA). Prior studies have shown that intramyocardial fat correlates with slow myocardial conduction velocity and with critical circuits for VA but the investigators do not know the causal relationship between intramyocardial fat and future risk of VA. Intramyocardial fat deposition or lipomatous metaplasia has been frequently observed in patients with ischemic heart disease and is readily detectable by multi-detector computed tomography (MDCT) with high sensitivity and specificity. Like intramyocardial fat, reentrant ventricular tachycardia (VT) tends to occur late after the onset of myocardial infarction and the investigators hypothesize that there may be a causal relationship. Prior studies have shown that intramyocardial fat correlates with slow myocardial conduction velocity and with critical circuits for VT in patients referred for VT ablation who already manifest VA. However, the correlation of intramyocardial fat on CT with late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) in a general population of patients with ischemic cardiomyopathy with no prior history of VA has not been reported. Specifically, it is unknown whether the presence, distribution and/or volume of fat is an independent predictor of VA. Further CMR is less widely available in medical centers, and is more expensive with longer scanning times compared to CT. CT provides higher spatial resolution, is widely available and is not as susceptible to magnetic interference from internal cardiac defibrillator (ICD) generators and thus makes it an attractive imaging modality for risk stratification, particularly longitudinally over time. Hypothesis: The investigators' objective is to define the prevalence and distribution of intramyocardial fat in patients with ischemic heart disease scheduled for or with in-situ implantable defibrillators. Further, the investigators aim to assess the independent association of intramyocardial fat with VA and determine whether it adds any utility above LGE measured by CMR. Finally, the investigators will assess how well delayed enhanced CT correlates with LGE on MRI and test its association with ventricular arrhythmias. Importance: The significance of the investigators' research is that the investigators will: 1) test whether intramyocardial fat on CT can be used as a non-invasive tool for sudden cardiac death risk stratification in patients who have or are scheduled to undergo ICDs, and 2) define whether delayed enhancement CT is comparable to the current non-invasive gold standard of CMR for identifying myocardial scar. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04394637
Study type Observational
Source Johns Hopkins University
Contact
Status Enrolling by invitation
Phase
Start date March 4, 2021
Completion date May 2026

See also
  Status Clinical Trial Phase
Completed NCT02275104 - Multimodal Image Processing Software to Guide Cardiac Ablation Therapy N/A
Completed NCT02699255 - Ventricular Arrhythmias After Pulmonary Vein Isolation
Recruiting NCT06281977 - Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm Phase 3
Completed NCT02772380 - Acute Study to Collect Electrical Signals From the Heart Using a Special Lead N/A
Recruiting NCT01771172 - Acute Subcutaneous Defibrillation N/A
Completed NCT00146679 - Psychoeducational Intervention for ICD Patients (PEACE) N/A
Completed NCT04495712 - Antiarrhythmic Effects of Spironolactone in Patients With ICDs Phase 4
Active, not recruiting NCT01864031 - The Role of Alcohol Consumption in the Aetiology of Different Cardiovascular Disease Phenotypes: a CALIBER Study N/A
Terminated NCT02227121 - Acute Defibrillation Study N/A
Active, not recruiting NCT01296022 - A PRospective, rAndomizEd Comparison of subcuTaneOous and tRansvenous ImplANtable Cardioverter Defibrillator Therapy N/A
Completed NCT00996086 - Risk Stratification and Benefits With Cardiac Resynchronization Therapy (CRT)
Recruiting NCT01905007 - Study of Defibrillation Testing In Patients Undergoing Initial ICD Implantation Phase 4
Active, not recruiting NCT02864771 - Scandinavian Multicenter Study to Advance Risk Stratification in Heart Disease- Ventricular Arrhythmias
Recruiting NCT04921501 - Evaluation of Electrocardiographic Measurements by High Density Electrode ECG (ECG-HD) N/A
Completed NCT01594073 - Evaluation of Novel Biomarkers to Improve Risk Stratification and Patient Selection in Implantable Cardioverter-defibrillator (ICD) Therapy
Completed NCT00273195 - Clinical Investigation of the Medtronic EnTrustâ„¢ Implantable Cardioverter Defibrillator (ICD), Model D153ATG N/A